Fundz

CUTISS secures €57.9M Series C to advance regenerative skin therapies, with contributions from existing and new investors.

PRIVATESep 10, 2025

Amount Raised

€57.9 Million

Round Type

Series C

SchlierenBiotechnologyHealth Careresearch

Description

Today CUTISS announced the closing of its Series C round for €57.9 million, bringing total funds raised to more than €129.3 million. Established in 2017, CUTISS focuses on tissue engineering therapies for skin surgery. Its lead product, denovoSkin, promises to transform skin surgery for burn victims. Despite investor hesitation, the company successfully attracted strong interest and secured the funding needed to continue its advancements.

Quick answer

CUTISS raised €57.9 Million in a Series C round, dated September 10, 2025. CUTISS is based in Schlieren, Zurich, Switzerland.

How much did CUTISS raise?
CUTISS raised €57.9 Million in a Series C round on September 10, 2025.
What does CUTISS do?
CUTISS is a late-stage clinical TechBio company focused on tissue therapeutics and regenerative medicine.
Where is CUTISS based and how big is it?
CUTISS is based in Schlieren, Zurich, Switzerland. Fundz records about 42 employees.
Who are the decision-makers at CUTISS?
Fundz holds 1 contact at CUTISS. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in research and Biotechnology around the same time

Companies in the same sectors as CUTISS that raised within 45 days of this round, from Fundz verified event records.

  • Faeth Therapeutics raised $25M (Funding Round) on October 20, 2025.
  • Grail raised $325M (Post-IPO Equity) on October 20, 2025.
  • Cyclana Bio raised $6.7M (Pre-Seed) on October 20, 2025.
  • Bexorg raised $23M (Series A) on October 16, 2025.
  • Adcytherix raised $122M (Series A) on October 16, 2025.
  • Kardigan raised $254M (Series B) on October 14, 2025.

Who to call at CUTISS, and when

A new round usually means CUTISS is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CUTISS raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CUTISS, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CUTISS. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CUTISS

Location

11 Grabenstrasse

Schlieren, Zurich, Switzerland

About

CUTISS is a late-stage clinical TechBio company focused on tissue therapeutics and regenerative medicine. Established in 2017 as a spin-off from the University of Zurich, it specializes in developing bio-engineered, personalized skin grafts. Its lead product, denovoSkin, aims to revolutionize skin surgery, particularly for burn victims, by offering effective, near-scarless healing. The company is dedicated to significantly improving quality of life for patients undergoing skin surgery.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CUTISS raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for CUTISS's next move

See what Strategic adds

CUTISS raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.